{"id":2964,"text":"Herb–drug interactions strongly challenge the clinical combined application of herbs and drugs.","label":[],"Comments":[]}
{"id":2965,"text":"Herbal products consist of complex pharmacological-active ingredients and perturb the activity of drug-metabolizing enzymes.","label":[[0,15,"Herb name"],[82,123,"Parameter"]],"Comments":[]}
{"id":2966,"text":"Panax notoginseng saponins (PNS)-based drugs are often combined with aspirin in vascular disease treatment in China.","label":[[0,32,"Herb name"],[69,76,"Drug"],[80,96,"Pathology"]],"Comments":[]}
{"id":2967,"text":"PNS was found to exhibit inhibitory effects on aspirin hydrolysis using Caco-2 cell monolayers.","label":[[0,3,"Herb name"],[47,54,"Drug"],[47,65,"Parameter"]],"Comments":[]}
{"id":2968,"text":"In the present study, a total of 22 components of PNS were separated and identified by UPLC-MS\/MS.","label":[[50,53,"Herb name"]],"Comments":[]}
{"id":2969,"text":"Using highly selective probe substrate analysis, PNS exerted robust inhibitory potency on human carboxylesterase 2 (hCE2), while had a minor influence on hCE1, butyrylcholinesterase (BChE) and paraoxonase (PON).","label":[[49,52,"Herb name"],[90,121,"Target"],[154,158,"Target"],[160,188,"Target"],[193,210,"Target"]],"Comments":[]}
{"id":2970,"text":"These effects were also verified through molecular docking analysis.","label":[],"Comments":[]}
{"id":2971,"text":"PNS showed a concentration-dependent inhibitory effect on hydrolytic activity of aspirin in HepaRG cells.","label":[[0,3,"Herb name"],[13,26,"Parameter"],[58,88,"Parameter"],[81,88,"Drug"]],"Comments":[]}
{"id":2972,"text":"The protein level of hCE2 in HepaRG cells was suppressed after PNS treatment, while the level of BChE or PON1 in the extracellular matrix were elevated after PNS treatment.","label":[[0,25,"Parameter"],[63,66,"Herb name"],[84,109,"Parameter"],[158,161,"Herb name"]],"Comments":[]}
{"id":2973,"text":"Insignificant effect was observed on the mRNA expression of the esterases.","label":[[37,73,"Parameter"]],"Comments":[]}
{"id":2974,"text":"These findings are important to understand the underlying efficacy and safety of co-administration of PNS and aspirin in clinical practice.","label":[[102,105,"Herb name"],[110,117,"Drug"]],"Comments":[]}
{"id":2975,"text":"Herbs have been used for primary health care for thousands of years before the advent of modern medicines.","label":[[0,5,"Herb name"],[45,67,"Duration"]],"Comments":[]}
{"id":2976,"text":"It is estimated that approximately 80% of the population in Asian countries currently uses herbs as complementary or alternative medicine [1].","label":[[60,65,"Ethnic group"],[91,96,"Herb name"]],"Comments":[]}
{"id":2977,"text":"Patients in these countries with complex diseases use herbs more frequently.","label":[[33,49,"Pathology"],[54,59,"Herb name"]],"Comments":[]}
{"id":2978,"text":"However, side effects of herb-drug interactions (HDI) might occur.","label":[],"Comments":[]}
{"id":2979,"text":"Some research reported that herbs perturbed the activities of the metabolizing enzymes and\/or transporters [2,3,4].","label":[[28,33,"Herb name"],[62,106,"Parameter"]],"Comments":[]}
{"id":2980,"text":"In the past decades, concerns about HDI have been raised.","label":[],"Comments":[]}
{"id":2981,"text":"Liver is the primary drug metabolism site and entails a myriad of chemical reactions.","label":[],"Comments":[]}
{"id":2982,"text":"HepaRG cell line, derived from a hepatocellular carcinoma, could express a large panel of liver-specific enzymes [5,6,7].","label":[[48,57,"Pathology"],[90,112,"Parameter"]],"Comments":[]}
{"id":2983,"text":"Due to the similarity with primary human hepatocytes, HepaRG cell line was found to be a valuable human-relevant in vitro model for testing drug interactions [8].","label":[],"Comments":[]}
{"id":2984,"text":"Panax notoginseng saponins (PNS) are the main biologically active constituents in the roots of Panax notoginseng (family Araliaceae).","label":[[0,32,"Herb name"],[86,91,"Herb part"],[95,132,"Herb name"]],"Comments":[]}
{"id":2985,"text":"In China, PNS-based drugs have been developed and widely used to treat cerebral infarction and ischemia [9], coronary heart disease and atherosclerosis [10].","label":[[10,13,"Herb name"],[71,151,"Pathology"]],"Comments":[]}
{"id":2986,"text":"Aspirin (acetylsalicylic acid) is an important member of the therapeutic arsenal for combating the vascular disease.","label":[[0,30,"Drug"],[95,115,"Pathology"]],"Comments":[]}
{"id":2987,"text":"After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12].","label":[[22,29,"Drug"],[69,93,"Parameter"],[110,116,"Duration"]],"Comments":[]}
{"id":2988,"text":"Aspirin and PNS-based drugs are often taken together to prevent thrombus and clinical benefits have been obtained.","label":[[0,7,"Drug"],[12,15,"Herb name"],[64,72,"Pathology"]],"Comments":[]}
{"id":2989,"text":"On account of the presence of ester bond, aspirin could be catalyzed by esterases in the intestine, liver, and plasma [13], which mainly include human carboxylesterase 1 (hCE1) and hCE2 in the liver and intestine [14,15], and butyrylcholinesterase (BChE) [16], paraoxonase (PON) [17,18] in plasma.","label":[[42,49,"Drug"],[72,81,"Parameter"],[145,185,"Parameter"],[226,254,"Parameter"],[261,278,"Parameter"]],"Comments":[]}
{"id":2990,"text":"We recently reported that PNS could inhibit aspirin hydrolysis and thereby elevated the level of aspirin through Caco-2 cell monolayers [19].","label":[[26,29,"Herb name"],[44,51,"Drug"],[44,62,"Parameter"],[84,104,"Parameter"],[97,104,"Drug"]],"Comments":[]}
{"id":2991,"text":"However, the influence of PNS on the esterases responsible for aspirin hydrolysis has not been fully investigated yet.","label":[[26,29,"Herb name"],[33,46,"Parameter"],[63,70,"Drug"],[63,81,"Parameter"]],"Comments":[]}
{"id":2992,"text":"In the current study, we characterized the effects of PNS on the esterases using highly selective probe substrates and predicted the potential HDI in vivo on the basis of enzyme kinetic parameters of hCE2.","label":[[54,57,"Herb name"],[61,73,"Parameter"],[171,204,"Parameter"]],"Comments":[]}
{"id":2993,"text":"The effects toward hCE2 were verified through molecular docking with PNS.","label":[[19,23,"Target"],[69,72,"Herb name"]],"Comments":[]}
{"id":2994,"text":"Further, we explored the possible HDI using the HepaRG cell line.","label":[],"Comments":[]}
{"id":2995,"text":"The main chemical components of PNS were detected with UPLC\/LTQ-Orbitrap MS\/MS analysis.","label":[[32,35,"Herb name"]],"Comments":[]}
{"id":2996,"text":"A total of 22 compounds were identified or tentatively identified (Figure 1).","label":[],"Comments":[]}
{"id":2997,"text":"The retention time, m\/z values of adduct ions and MS\/MS fragment ions in negative ESI modes, mass error, and formula of all the identified compounds were listed in Table 1.","label":[[0,18,"Parameter"],[20,69,"Parameter"]],"Comments":[]}
{"id":2998,"text":"The chemical analysis was conducted to evaluate the influence on the esterases responsible for aspirin hydrolysis.","label":[[65,78,"Parameter"],[95,102,"Drug"],[95,113,"Parameter"]],"Comments":[]}
{"id":2999,"text":"Compared with the positive inhibitors (bis-p-nitrophenyl phosphate, tetraisopropyl pyrophosphoramide and ethylenediaminetetracetic acid, which are abbreviated as BNPP, iso-OMPA and EDTA in order), PNS exhibited weak or negligible effects on hCE1 (Figure 2A), BChE (Figure 2B), and PON (Figure 2C).","label":[[39,66,"Parameter"],[68,100,"Parameter"],[105,135,"Parameter"],[162,166,"Parameter"],[168,176,"Parameter"],[181,185,"Parameter"],[197,200,"Herb name"],[241,245,"Target"],[259,263,"Target"],[281,284,"Target"]],"Comments":[]}
{"id":3000,"text":"In contrast, PNS strikingly reduced hCE2 activity in a concentration-dependent manner (Figure 2D).","label":[[13,16,"Herb name"],[36,40,"Target"],[36,49,"Parameter"],[55,68,"Parameter"]],"Comments":[]}
{"id":3001,"text":"Further, inhibition kinetic analysis was carried out to investigate the mechanism of PNS toward hCE2.","label":[[85,88,"Herb name"],[96,100,"Target"]],"Comments":[]}
{"id":3002,"text":"The half inhibition concentration (IC A clinical study reported that the integrated peak concentration (C Molecular docking programs use scoring functions to evaluate the binding energy of predicting ligand-receptor complex.","label":[[0,37,"Parameter"],[38,54,"Study"],[69,105,"Parameter"]],"Comments":[]}
{"id":3003,"text":"The binding scores between PNS and hCE2 were shown in Table 2.","label":[[27,30,"Herb name"],[35,39,"Parameter"]],"Comments":[]}
{"id":3004,"text":"The interaction energy between PNS and the metabolic enzyme varied from −8.8 kJ\/mol to −5.5 kJ\/mol reflecting the stability of the complex.","label":[[0,59,"Parameter"],[31,35,"Herb name"],[39,59,"Parameter"],[72,83,"Amount"],[87,98,"Amount"]],"Comments":[]}
{"id":3005,"text":"Among 22 compounds in PNS, the five main compounds (notoginsenoside R The effects of PNS exposure in HepaRG cells was conducted by an MTT assay to set the concentrations used in the following trials, using the medium-treated cells group as control.","label":[[22,25,"Herb name"],[52,69,"Herb name"],[85,88,"Herb name"],[151,169,"Parameter"]],"Comments":[]}
{"id":3006,"text":"As shown in Figure 6, cell viability of PNS-treated cells changed in a concentration-dependent manner and exhibited no cytotoxicity effect under the concentration of 100 µg\/mL.","label":[[22,57,"Parameter"],[40,43,"Herb name"],[71,84,"Parameter"],[119,139,"Pathology"],[145,162,"Parameter"],[166,175,"Amount"]],"Comments":[]}
{"id":3007,"text":"The property of esterases responsible for aspirin hydrolysis in HepaRG cells was investigated in an inhibition experiment.","label":[[16,25,"Parameter"],[42,49,"Drug"],[42,60,"Parameter"]],"Comments":[]}
{"id":3008,"text":"The results were presented in Figure 7.","label":[],"Comments":[]}
{"id":3009,"text":"The hydrolase activity was significantly inhibited by the addition of BNPP, a specific inhibitor of hCE1 or hCE2.","label":[[0,22,"Parameter"],[70,112,"Parameter"],[100,104,"Target"],[108,112,"Target"]],"Comments":[]}
{"id":3010,"text":"However, there was no significant inhibition on aspirin hydrolysis when treated with iso-OMPA or EDTA, hydrolase inhibitors for BChE and PON, respectively.","label":[[48,55,"Drug"],[48,66,"Parameter"],[85,93,"Parameter"],[97,101,"Parameter"],[128,132,"Target"],[137,140,"Target"]],"Comments":[]}
{"id":3011,"text":"Meaningfully, PNS significantly decreased the hydrolase activity of aspirin in a concentration-dependent manner.","label":[[14,17,"Herb name"],[42,75,"Parameter"],[68,75,"Drug"],[81,94,"Parameter"]],"Comments":[]}
{"id":3012,"text":"There was no significant difference between BNPP (68 µg\/mL) and PNS (150 µg\/mL).","label":[[44,48,"Parameter"],[50,58,"Amount"],[64,67,"Herb name"],[69,78,"Amount"]],"Comments":[]}
{"id":3013,"text":"These data indicated that PNS exhibited an appreciating efficiency in inhibiting aspirin hydrolysis.","label":[[26,29,"Herb name"],[81,88,"Drug"],[81,99,"Parameter"]],"Comments":[]}
{"id":3014,"text":"We further explored the role of PNS in the protein expression in HepaRG cells.","label":[[32,35,"Herb name"],[39,61,"Parameter"]],"Comments":[]}
{"id":3015,"text":"The results of the expression of hCE1, hCE2, BChE, and PON1 in HepaRG cells after PNS treatment were presented in Figure 8.","label":[[33,37,"Parameter"],[39,43,"Parameter"],[45,49,"Parameter"],[55,59,"Parameter"],[82,85,"Herb name"]],"Comments":[]}
{"id":3016,"text":"There was no significant influence on hCE1 expression compared to the control (Figure 8A), while PNS (100 µg\/mL) significantly reduced hCE2 protein level (p < 0.05) (Figure 8B).","label":[[38,53,"Parameter"],[97,100,"Herb name"],[102,111,"Amount"],[135,153,"Parameter"]],"Comments":[]}
{"id":3017,"text":"Though BChE levels intracelluar was not significantly changed compared to the control, PNS (100 µg\/mL) led to the great rise in the extracelluler medium (Figure 8C,D).","label":[[7,31,"Parameter"],[87,90,"Herb name"],[92,101,"Amount"]],"Comments":[]}
{"id":3018,"text":"The same situation was also seen in PON1 (Figure 8E,F).","label":[[36,40,"Parameter"]],"Comments":[]}
{"id":3019,"text":"To elucidate the effect of PNS on the transcription factor contributed to the change of the protein level of esterases, we also explored mRNA expression in HepaRG cells with PNS treatment.","label":[[27,30,"Herb name"],[34,58,"Parameter"],[88,118,"Parameter"],[137,152,"Parameter"],[174,177,"Herb name"]],"Comments":[]}
{"id":3020,"text":"Compared with the control, there was no significant difference on the mRNA expression of hCE1, hCE2, BChE, and PON1 (Figure 9).","label":[[66,115,"Parameter"]],"Comments":[]}
{"id":3021,"text":"Multi-drug therapy is now a common therapeutic practice for patients due to their therapeutic benefits, in both developed and developing countries.","label":[],"Comments":[]}
{"id":3022,"text":"As a consequence, drug interactions are sometimes unavoidable.","label":[],"Comments":[]}
{"id":3023,"text":"Apart from cytochrome P450, esterases is an important class of phase I metabolic enzymes, and plays a vital role in the biotransformation of ester-linked compounds.","label":[[11,26,"Parameter"],[28,37,"Parameter"]],"Comments":[]}
{"id":3024,"text":"Drugs with the ability to inhibit the catalytic activity of esterases in the body might improve systemic exposure of the drug which is primarily cleared via the esterases.","label":[[34,69,"Parameter"],[60,69,"Target"],[157,170,"Parameter"]],"Comments":[]}
{"id":3025,"text":"Except for synthetic compounds, many natural triterpenoids have been reported to exhibit the potent inhibitory effects on esterases in recent years [21,22,23].","label":[[37,58,"Herb name"],[122,131,"Target"]],"Comments":[]}
{"id":3026,"text":"Aspirin is one of the oldest antiplatelet agents used for antithrombotic therapy.","label":[[0,7,"Drug"],[58,80,"Drug"]],"Comments":[]}
{"id":3027,"text":"It is rapidly hydrolyzed to salicylic acid by esterases in the body.","label":[[28,42,"Drug"],[46,55,"Parameter"]],"Comments":[]}
{"id":3028,"text":"Compared with other esterases, it has been reported that aspirin was primarily hydrolyzed by hCE2 [15].","label":[[20,29,"Parameter"],[57,64,"Drug"],[93,97,"Parameter"]],"Comments":[]}
{"id":3029,"text":"In China, aspirin and PNS-based drugs are often taken together under many conditions and produce enhanced therapeutic effects.","label":[[10,17,"Drug"],[22,25,"Herb name"]],"Comments":[]}
{"id":3030,"text":"In our previous study, the plasma concentration of salicylic acid was highly increased when PNS and aspirin were co-administrated in SD rats, indicating that the HDI in vivo definitely existed in both drugs [24].","label":[[23,66,"Parameter"],[51,65,"Drug"],[92,95,"Herb name"],[100,107,"Drug"]],"Comments":[]}
{"id":3031,"text":"In addition, using Caco-2 cell monolayers model, we demonstrated that PNS exhibited appreciative inhibitory ability on the activity of the esterases responsible for aspirin hydrolysis, resulting in the elevated level of aspirin across Caco-2 cell monolayers [19].","label":[[70,73,"Herb name"],[119,148,"Parameter"],[135,148,"Target"],[165,172,"Drug"],[165,183,"Parameter"],[220,227,"Drug"]],"Comments":[]}
{"id":3032,"text":"Highly-selective probe substrate analysis is extensively used for determination of the inhibitory potential of a test compound.","label":[],"Comments":[]}
{"id":3033,"text":"The basic premise of the methodology is that if test compounds cannot inhibit a particular metabolic enzyme, the probe substrate will be metabolized to its product (metabolite) which can then be measured.","label":[[78,107,"Parameter"]],"Comments":[]}
{"id":3034,"text":"Conversely, if test compounds inhibit the enzyme, the substrate will not be metabolized or the rate of biotransformation and the formation of product declines [25].","label":[[38,48,"Target"]],"Comments":[]}
{"id":3035,"text":"In the study, we used probe substrate analysis to explore the inhibitory effects of PNS toward esterases.","label":[[84,87,"Herb name"],[95,104,"Target"]],"Comments":[]}
{"id":3036,"text":"The results demonstrated that PNS exhibited strong inhibitory influence toward hCE2, whereas displayed weak inhibition toward hCE1, BChE, and PON with IC Theoretically, significant enzyme inhibition occurs when the concentration of the inhibitor at the metabolic site is not lower than the K Molecular docking is the widely used methods to investigate structure-activity relationships owing to the predictive ability of the conformation of small-molecule ligands within receptor binding sites [28].","label":[[30,33,"Herb name"],[79,83,"Target"],[126,130,"Target"],[132,136,"Target"],[142,145,"Target"],[211,267,"Parameter"]],"Comments":[]}
{"id":3037,"text":"By executing quantitative predictions of binding energetics, molecular docking provided rankings of docked compounds on the basis of the binding affinity of complexes [29,30].","label":[],"Comments":[]}
{"id":3038,"text":"The main saponins presented in PNS include notoginsenoside R Almost all herbal drugs undergo phase I and\/or phase II metabolism to yield inactive or active metabolites.","label":[[9,17,"Herb name"],[31,34,"Herb name"],[43,60,"Herb name"]],"Comments":[]}
{"id":3039,"text":"Herbal drugs are made of a complex mixture of pharmacological active phytochemicals [32].","label":[[0,12,"Herb name"]],"Comments":[]}
{"id":3040,"text":"This complexity may act as inhibitors or inducers of liver drug enzymes, thus altering the other drug’s concentration in target sites and influencing therapeutic effects [2].","label":[[53,71,"Parameter"],[104,117,"Parameter"]],"Comments":[]}
{"id":3041,"text":"Liver drug enzymes are the common sites of drug interaction in human.","label":[[0,18,"Parameter"]],"Comments":[]}
{"id":3042,"text":"HepaRG cell line can express esterases responsible for aspirin hydrolysis.","label":[[29,38,"Parameter"],[55,62,"Drug"],[55,73,"Parameter"]],"Comments":[]}
{"id":3043,"text":"In the inhibition experiment, we observed an interesting phenomenon that the hydrolysis of aspirin was inhibited by PNS.","label":[[77,98,"Parameter"],[91,98,"Drug"],[116,119,"Herb name"]],"Comments":[]}
{"id":3044,"text":"Thus, it is possible that the inhibitory effects of aspirin hydrolysis triggered by PNS occurred as it travels through human liver.","label":[[52,59,"Drug"],[52,70,"Parameter"],[84,87,"Herb name"]],"Comments":[]}
{"id":3045,"text":"The results further support our studies above and are consistent with our earlier finding that PNS is an effective inhibitor of esterases.","label":[[95,98,"Herb name"],[128,137,"Target"]],"Comments":[]}
{"id":3046,"text":"We further explored the potential effects of PNS on the major esterases expressed in the human liver.","label":[[45,48,"Herb name"],[62,71,"Parameter"]],"Comments":[]}
{"id":3047,"text":"PNS reduced the protein level of hCE2 in HepaRG cells, indicating together regulation of protein expression other than the catalytic activity.","label":[[0,3,"Herb name"],[12,37,"Parameter"],[89,107,"Parameter"]],"Comments":[]}
{"id":3048,"text":"PON1 has been reported to be beneficial in preventing atherosclerosis, attributing to its ability to reduce lipid hydroperoxides [33].","label":[[0,4,"Parameter"],[54,69,"Pathology"],[108,128,"Parameter"]],"Comments":[]}
{"id":3049,"text":"Blatter–Garin et al.","label":[],"Comments":[]}
{"id":3050,"text":"reported that aspirin application can increase the PON1 activity in plasma [34].","label":[[14,21,"Drug"],[51,64,"Parameter"]],"Comments":[]}
{"id":3051,"text":"In this study, PNS increased the release of PON1 out of the HepaRG cells.","label":[[15,18,"Herb name"],[44,48,"Parameter"]],"Comments":[]}
{"id":3052,"text":"Considering PON1 catalyzing the hydrolysis of aspirin, this may balance the harmful and beneficial actions of PNS.","label":[[12,16,"Parameter"],[28,53,"Parameter"],[46,53,"Drug"],[110,113,"Herb name"]],"Comments":[]}
{"id":3053,"text":"Notably, PNS had insignificant effects on mRNA expression of four tested esterases.","label":[[9,12,"Herb name"],[42,57,"Parameter"],[73,82,"Parameter"]],"Comments":[]}
{"id":3054,"text":"Taken together, it was conceived that the effects of PNS might be related to the translation, processing, and stability of the esterases.","label":[[53,56,"Herb name"],[123,136,"Parameter"]],"Comments":[]}
{"id":3055,"text":"The findings from our study clearly indicated that PNS possess high potency in the inhibition of esterases, in particular hCE2.","label":[[51,54,"Herb name"],[97,106,"Target"],[122,126,"Target"]],"Comments":[]}
{"id":3056,"text":"Aspirin hydrolysis inhibited by PNS also had been confirmed on the cellular level.","label":[[0,7,"Drug"],[0,18,"Parameter"],[32,35,"Herb name"]],"Comments":[]}
{"id":3057,"text":"It is likely that PNS could result in HDI in the clinical practice when combined with aspirin.","label":[[18,21,"Herb name"],[86,93,"Drug"]],"Comments":[]}
{"id":3058,"text":"In many case, however, the effects of some drug in vitro and in vivo have no inevitable correlation.","label":[],"Comments":[]}
{"id":3059,"text":"A further study is warranted to investigate the HDI of PNS and aspirin in large test animals.","label":[[55,58,"Herb name"],[63,70,"Drug"]],"Comments":[]}
{"id":3060,"text":"Aspirin was obtained from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China).","label":[[0,7,"Drug"]],"Comments":[]}
{"id":3061,"text":"PNS was obtained from Yunnan Sanqi Technology Co., Ltd. (Wenshan, China).","label":[[0,3,"Herb name"]],"Comments":[]}
{"id":3062,"text":"PNS contents were determined as: notoginsenoside R UPLC-MS\/MS analysis was conducted on an Ultimate 3000 UPLC system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an LTQ-Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA).","label":[[0,3,"Herb name"],[33,50,"Herb name"]],"Comments":[]}
{"id":3063,"text":"The chromatographic column used was an ACQUICTY UPLC The highly selectively probe substrates were used to evaluate the influence of PNS on esterases responsible for aspirin hydrolysis.","label":[[132,135,"Herb name"],[139,148,"Parameter"],[165,172,"Drug"],[165,183,"Parameter"]],"Comments":[]}
{"id":3064,"text":"The chemical assays for hCE1 and hCE2 were performed according to the methods reported by Wang et al.","label":[[24,28,"Parameter"],[33,37,"Parameter"]],"Comments":[]}
{"id":3065,"text":"[35] and Wang et al.","label":[],"Comments":[]}
{"id":3066,"text":"[36], respectively.","label":[],"Comments":[]}
{"id":3067,"text":"The study on the effects of BChE was conducted using the method by Gulcin et al.","label":[[28,32,"Parameter"]],"Comments":[]}
{"id":3068,"text":"[37].","label":[],"Comments":[]}
{"id":3069,"text":"The influence test for PON was conducted by the method of Furlong et al.","label":[[23,26,"Parameter"]],"Comments":[]}
{"id":3070,"text":"[38] with some modifications.","label":[],"Comments":[]}
{"id":3071,"text":"Briefly, the reaction system contained fresh plasma and freshly prepared paraoxon substrate solution (1 mM) in a total of 200 µL of assay buffer (pH 8.0, 20 mM Tris-HCl, 1 mM CaCl Known inhibitors were run in triplicate as positive controls: BNPP for hCE1 or hCE2, iso-OMPA for BChE, and EDTA for PON.","label":[[73,100,"Parameter"],[102,106,"Amount"],[122,128,"Amount"],[146,148,"Parameter"],[149,152,"Amount"],[160,168,"Extraction process"],[170,174,"Amount"],[175,179,"Parameter"],[242,246,"Parameter"],[251,255,"Parameter"],[258,263,"Parameter"],[265,273,"Parameter"],[278,282,"Parameter"],[288,292,"Parameter"],[297,300,"Parameter"]],"Comments":[]}
{"id":3072,"text":"The K The likelihood of HDI in vivo was predicted based on the [I] and K Molecular docking studies were performed to investigate the binding mode of PNS to hCE2 by using AutodockVina 1.1.2 ( HepaRG cells were generously provided by Du Yanan (Tsinghua University, Beijing, China).","label":[[149,152,"Herb name"],[156,160,"Parameter"]],"Comments":[]}
{"id":3073,"text":"Cells were cultured in growth medium composed of Williams’ E medium supplemented with 12% fetal bovine serum (FBS), 100 U\/mL penicillin, 100 µg\/L streptomycin, 5 mg\/mL insulin, 2 mM glutamax-I, and 50 µM hydrocortisone hemisuccinate under 5% CO The cell viability was examined by the methyl thiazolyl tetrazolium (MTT) assay.","label":[[86,89,"Amount"],[90,114,"Parameter"],[116,124,"Amount"],[125,135,"Drug"],[137,145,"Amount"],[146,158,"Drug"],[160,167,"Amount"],[168,175,"Drug"],[177,181,"Amount"],[182,192,"Parameter"],[198,203,"Amount"],[204,232,"Drug"],[233,241,"Amount"],[242,244,"Parameter"],[245,263,"Parameter"]],"Comments":[]}
{"id":3074,"text":"HepaRG cells were seeded into 96-well plates at 5 × 10 The changes of aspirin hydrolysis in HepaRG cell homogenates after the addition of PNS was investigated.","label":[[70,77,"Drug"],[70,88,"Parameter"],[138,141,"Herb name"]],"Comments":[]}
{"id":3075,"text":"The harvested cells were suspended in ice-cold buffer and then homogenized using an ultrasonic homogenizer under the ice-cold condition.","label":[],"Comments":[]}
{"id":3076,"text":"The cell homogenate was diluted with HEPES buffer to the appropriate protein concentrations.","label":[[69,91,"Parameter"]],"Comments":[]}
{"id":3077,"text":"PNS was added to the reaction solution and pre-incubated for 5 min.","label":[[0,3,"Herb name"],[57,66,"Duration"]],"Comments":[]}
{"id":3078,"text":"The reaction was then started by adding aspirin and terminated by adding ice-cold methanol.","label":[[40,47,"Drug"],[73,90,"Extraction process"]],"Comments":[]}
{"id":3079,"text":"After centrifugation, the supernatants containing acetic acid (final concentration of 2%) were determined using HPLC.","label":[[50,61,"Extraction process"],[69,82,"Parameter"],[86,88,"Amount"]],"Comments":[]}
{"id":3080,"text":"The chromatographic separation was achieved using a C The expression level of hCE1, hCE2, PON1, and BChE in HepaRG cells treated by PNS was quantitatively measured using ELISA Kit according to the manufacturer’s protocol.","label":[[54,104,"Parameter"],[132,135,"Herb name"]],"Comments":[]}
{"id":3081,"text":"Briefly, 2 × 10 Total RNA was extracted from the cells using the Trizol (CW0581, CWbio, Beijing, China).","label":[[9,15,"Amount"],[16,25,"Parameter"]],"Comments":[]}
{"id":3082,"text":"One microgram of RNA was used to synthesize cDNA using a reverse transcription reagents Kit (CW0744, CWbio, Beijing, China).","label":[[0,13,"Amount"],[17,20,"Parameter"],[44,48,"Parameter"]],"Comments":[]}
{"id":3083,"text":"The qRT-PCR analysis was then carried out using UltraSYBR (with ROX) on Line Gene 9600 Plus qRT-PCR Detection system (Bioer Technology, Hangzhou, China) in the one-step protocol.","label":[],"Comments":[]}
{"id":3084,"text":"Reactions were initiated at 95 °C for 10 min, followed by 45 cycles of 95 °C for 15 s and 60 °C for 60 s. Melting curve analysis was performed to confirm the specificity of primers.","label":[[28,30,"Amount"],[31,33,"Parameter"],[34,44,"Duration"],[71,73,"Amount"],[74,76,"Parameter"],[77,85,"Duration"],[90,92,"Amount"],[93,95,"Parameter"],[96,104,"Duration"]],"Comments":[]}
{"id":3085,"text":"The relative mRNA expressions of hCE1, hCE2, BChE, and PON1 mRNA were normalized to GAPDH and calculated using the 2 Statistical analysis was performed using Prism v5.0 (GraphPad Software Inc., San Diego, CA, USA).","label":[[13,59,"Parameter"],[84,89,"Parameter"]],"Comments":[]}
{"id":3086,"text":"Data were presented in the format of the mean ± SD from at least three independent measurements.","label":[],"Comments":[]}
{"id":3087,"text":"ANOVA was run to determine significance between groups in the different experiments.","label":[],"Comments":[]}
{"id":3088,"text":"A value of p < 0.05 was considered to be significant.","label":[],"Comments":[]}
{"id":3089,"text":"In conclusion, we provided the comprehensive in vitro data that enable us to understand and predict HDI with PNS.","label":[[109,112,"Herb name"]],"Comments":[]}
{"id":3090,"text":"PNS could directly affect the activity of esterases in vitro with varying potency with hCE2 being the most susceptible to inhibition.","label":[[0,3,"Herb name"],[26,51,"Parameter"],[87,91,"Parameter"]],"Comments":[]}
{"id":3091,"text":"Molecular docking revealed that PNS targeted hCE2 thus leading to its inhibition.","label":[[32,35,"Herb name"],[45,49,"Parameter"]],"Comments":[]}
{"id":3092,"text":"We further confirmed the inhibitory potential at the cellular level.","label":[],"Comments":[]}
{"id":3093,"text":"Our data also showed that PNS lead to the alteration of the esterase expression level, while exhibited insignificant effects on mRNA expression.","label":[[26,29,"Herb name"],[56,85,"Parameter"],[128,143,"Parameter"]],"Comments":[]}
{"id":3094,"text":"The present work provides an insight into the mechanism exploration governing HDI between aspirin and PNS.","label":[[90,97,"Drug"],[102,105,"Herb name"]],"Comments":[]}
{"id":3095,"text":"We hope that the findings will urge us to pay more attention to the underlying safety and efficiency of combined drugs in the clinic.","label":[],"Comments":[]}
{"id":3096,"text":"S.D.","label":[],"Comments":[]}
{"id":3097,"text":"and P.L.","label":[],"Comments":[]}
{"id":3098,"text":"conceived and designed the whole experiments.","label":[],"Comments":[]}
{"id":3099,"text":"Z.S.","label":[],"Comments":[]}
{"id":3100,"text":"and Y.W.","label":[],"Comments":[]}
{"id":3101,"text":"performed the experiments; S.L.","label":[],"Comments":[]}
{"id":3102,"text":"and S.H.","label":[],"Comments":[]}
{"id":3103,"text":"analyzed the data; and B.Z.","label":[],"Comments":[]}
{"id":3104,"text":"wrote the paper.","label":[],"Comments":[]}
{"id":3105,"text":"This work was supported by the Fundamental Research Funds for the Central Universities (No.","label":[],"Comments":[]}
{"id":3106,"text":"2017-JYB-XS-071).","label":[],"Comments":[]}
{"id":3107,"text":"The authors declare no conflict of interest.","label":[],"Comments":[]}
{"id":3108,"text":"The representative total ion current chromatogram of PNS in negative ESI modes.","label":[[53,56,"Herb name"]],"Comments":[]}
{"id":3109,"text":"The corresponding compound names were given in Table 1 (varying from no.","label":[],"Comments":[]}
{"id":3110,"text":"1 to 19).","label":[],"Comments":[]}
{"id":3111,"text":"Inhibitory effects of PNS toward the esterases of hCE1, BChE, PON and hCE2 (A–D in order) with BMBT (2-(2-benzoyloxy-3-methoxyphenyl)benzothiazole), FD (Fluorescein diacetate), BuSCh (S-Butyrylthiocholine chloride) and PA (phenyl acetate) as a highly selective substrate of each esterase.","label":[[22,25,"Herb name"],[33,74,"Target"],[95,147,"Parameter"],[149,175,"Parameter"],[177,214,"Parameter"],[219,238,"Parameter"],[279,287,"Parameter"]],"Comments":[]}
{"id":3112,"text":"BNPP, iso-OMPA, and EDTA are well-known inhibitors for hCE1 (hCE2), BChE, and PON, respectively.","label":[[0,24,"Parameter"],[55,81,"Target"]],"Comments":[]}
{"id":3113,"text":"Data were presented as mean ± SD (n = 3).","label":[],"Comments":[]}
{"id":3114,"text":"Various concentrations of PNS were used to measure the half inhibition concentration toward hCE2.","label":[[26,29,"Herb name"],[51,96,"Parameter"]],"Comments":[]}
{"id":3115,"text":"Each point represents the mean of three independent experiments.","label":[],"Comments":[]}
{"id":3116,"text":"Inhibitory kinetics of PNS toward hCE2 using Lineweaver-Burk plots (A) and Dixon plots (B).","label":[[23,26,"Herb name"],[34,38,"Target"]],"Comments":[]}
{"id":3117,"text":"Data were presented as mean ± SD (n = 3).","label":[],"Comments":[]}
{"id":3118,"text":"Molecular docking mode and interactions between hCE2 (shown in cartoon representation and colored structure) and notoginsenoside R Cytotoxicity tests of PNS on HepaRG cells.","label":[[48,52,"Parameter"],[113,130,"Herb name"],[153,156,"Herb name"]],"Comments":[]}
{"id":3119,"text":"Data were presented as mean ± SD (n = 5).","label":[],"Comments":[]}
{"id":3120,"text":"** and *** denoted result significantly different from that of the control group (p < 0.01 and p < 0.001, respectively).","label":[],"Comments":[]}
{"id":3121,"text":"Hydrolysis of aspirin (ASA) in HepaRG cell homogenates treated with PNS.","label":[[0,28,"Parameter"],[14,27,"Drug"],[68,71,"Herb name"]],"Comments":[]}
{"id":3122,"text":"HepaRG cells homogenates were prepared and then diluted with 50 mM HEPES buffer (pH 7.4).","label":[[61,79,"Extraction process"],[81,83,"Parameter"],[84,87,"Amount"]],"Comments":[]}
{"id":3123,"text":"Hydrolysis of ASA (1.8 µg\/mL) in cell homogenates was conducted in the presence\/absence of PNS.","label":[[0,17,"Parameter"],[14,17,"Drug"],[19,28,"Amount"],[91,94,"Herb name"]],"Comments":[]}
{"id":3124,"text":"No significance (ns) was detected between BNPP (68 µg\/mL) and PNS (150 µg\/mL) treated group.","label":[[42,46,"Parameter"],[48,56,"Amount"],[62,65,"Herb name"],[67,76,"Amount"]],"Comments":[]}
{"id":3125,"text":"Data were presented as mean ± SD (n = 3).","label":[],"Comments":[]}
{"id":3126,"text":"*, and ** denoted results significantly different compared with the control group (p < 0.05, p < 0.01, respectively).","label":[],"Comments":[]}
{"id":3127,"text":"Effects on human carboxylesterase 1 (hCE1) (A), hCE2 (B), BChE (C,D), and PON1 (E,F) protein level after PNS treatment.","label":[[11,98,"Parameter"],[105,108,"Herb name"]],"Comments":[]}
{"id":3128,"text":"Cells were incubated with PNS for up to 24 h. After the removal of PNS, cell lysates were prepared for ELISA analysis.","label":[[26,29,"Herb name"],[34,44,"Duration"],[67,70,"Herb name"]],"Comments":[]}
{"id":3129,"text":"Data were presented as mean ± SD (n = 3).","label":[],"Comments":[]}
{"id":3130,"text":"* and ** denote results significantly different from those of the control group (p < 0.05, p < 0.01, respectively).","label":[],"Comments":[]}
{"id":3131,"text":"Effects on mRNA expression of human carboxylesterase 1 (hCE1) (A), hCE2 (B), BChE (C), and PON1 (D) with PNS treatment.","label":[[11,26,"Parameter"],[30,95,"Parameter"],[105,108,"Herb name"]],"Comments":[]}
{"id":3132,"text":"Cells were incubated with PNS for up to 24 h. After the removal of PNS, total mRNA was prepared for qRT-PCR.","label":[[26,29,"Herb name"],[30,44,"Duration"],[67,70,"Herb name"],[72,82,"Parameter"]],"Comments":[]}
{"id":3133,"text":"Data were presented as mean ± SD (n = 3).","label":[],"Comments":[]}
{"id":3134,"text":"All the identified or tentatively identified components of PNS and their UPLC-MS\/MS data.","label":[[59,62,"Herb name"]],"Comments":[]}
{"id":3135,"text":"Docking scores between the compounds of PNS and hCE2.","label":[[40,43,"Herb name"],[48,52,"Parameter"]],"Comments":[]}
{"id":3136,"text":"Primer sequences for qRT-PCR.","label":[],"Comments":[]}
